With a refreshing feel and smooth lather, Vita Glow Soap leaves skin feeling clean, soft, and comfortable after every wash
A phase 1 multiple-ascending dose study of tirzepatide in Japanese participants with type 2 diabetes
Raghunath, S., Glikmann-Johnston, Y., Hanly, J
Published preclinical research on FOXO4-DRI has demonstrated selective elimination of senescent cells in mouse models, with observed improvements in fitness markers, fur density, and organ function in aged subjects
Key considerations from available evidence: No direct hormonal mechanism linking tirzepatide to menstrual disruption has been identified Metabolic improvements (reduced insulin resistance, decreased androgens) may benefit women with PCOS The magnitude and rapidity of weight loss correlate with likelihood of temporary menstrual changes Long-term data on reproductive outcomes remain limited Healthcare providers should counsel women of reproductive age about potential menstrual changes when initiating tirzepatide